ACR适宜性标准®痴呆
中枢神经系统退行性疾病是日益增长的公共卫生问题。神经影像在可能或很可能阿尔茨海默病检查中的主要作用是排除其他显著颅内异常;结构MRI表现非特异,鉴别痴呆类型潜力有限;FDG-PET有助于专家评估的患者鉴别阿尔茨海默病与额颞叶痴呆;多巴胺转运体SPECT可能有助于疑似路易体痴呆;疑似正常压力脑积水可评估。
要点
- 结构MRI在痴呆检查中的主要作用是排除其他显著颅内异常,对痴呆分型价值有限。
- FDG-PET可帮助痴呆专家将阿尔茨海默病与额颞叶痴呆区分开。
- 疑似路易体痴呆时,多巴胺转运体(ioflupane)SPECT功能成像可能有帮助。
临床应用与阅片要点
- 结构MRI表现非特异,鉴别不同痴呆类型潜力有限,主要用途是排除其他显著颅内异常。
- 先进影像方法不常规用于社区或一般实践中的痴呆诊断或分型。
- 经痴呆专家评估的患者,FDG-PET有助于区分阿尔茨海默病与额颞叶痴呆。
- 疑似路易体痴呆患者,使用ioflupane的多巴胺转运体SPECT功能成像可能有帮助。
- 疑似正常压力脑积水患者,DTPA脑池造影和HMPAO SPECT/CT脑显像可提供评估。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Degenerative disease of the central nervous system is a growing public health concern. The primary role of neuroimaging in the workup of patients with probable or possible Alzheimer disease has typically been to exclude other significant intracranial abnormalities. In general, the imaging findings in structural studies, such as MRI, are nonspecific and have limited potential in differentiating different types of dementia. Advanced imaging methods are not routinely used in community or general practices for the diagnosis or differentiation of forms of dementia. Nonetheless, in patients who have been evaluated by a dementia expert, FDG-PET helps to distinguish Alzheimer disease from frontotemporal dementia. In patients with suspected dementia with Lewy bodies, functional imaging of the dopamine transporter (ioflupane) using SPECT may be helpful. In patients with suspected normal-pressure hydrocephalus, DTPA cisternography and HMPAO SPECT/CT brain may provide assessment. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment.
引用
- Moonis G, Subramaniam RM, Trofimova A, et al. ACR Appropriateness Criteria® Dementia. J Am Coll Radiol. 2020. PMID: 32370954. doi:10.1016/j.jacr.2020.01.040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。